Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study)

BACKGROUND: Paclitaxel plus ramucirumab (PTX + RAM) is the standard second-line chemotherapy for unresectable advanced or recurrent gastric cancer (AGC). Nanoparticle albumin-bound paclitaxel (nab-PTX) is an improved, more convenient form of PTX and is non-inferior to PTX. Although some retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakasya, Akio, Hagiwara, Yuya, Ikoma, Tatsuki, Kurioka, Yusuke, Matsumoto, Toshihiko, Yamamoto, Yoshiyuki, Tsuduki, Takao, Kajiwara, Takeshi, Moriwaki, Toshikazu, Nishina, Tomohiro, Yamashita, Natsumi, Hyodo, Ichinosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956527/
https://www.ncbi.nlm.nih.gov/pubmed/35089459
http://dx.doi.org/10.1007/s10147-022-02114-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956527/
https://www.ncbi.nlm.nih.gov/pubmed/35089459
http://dx.doi.org/10.1007/s10147-022-02114-y

Ejemplares similares